Short Description
Quantifies lipid accumulation in differentiated adipocytes.
Development Stage
Research-Grade Lipid Metabolism Assay Development
Description
The LipidFlux™ Adipogenesis Assay Kit uses a fluorometric lipid stain to quantify the differentiation of pre-adipocytes, enabling the screening of anti-obesity compounds. This assay validates drugs that modulate fat cell development and lipid accumulation. It supports metabolic research by providing a high-throughput method for assessing the impact of chemicals on adipocyte biology.
Features
Fluorometric lipid stain; Quantifies differentiation of pre-adipocytes in obesity drug screens.
Process Relevance
Obesity Drug Discovery
Application Stage
Hit-to-Lead Screening
Applications
Screening compounds for anti-obesity effects.
Qualified With
Internal performance validation using reference standards under defined assay conditions.
Detection Method
Absorbance at 570 nm or Fluorescence Detection (Ex 530 nm / Em 585 nm)
Sample Type
Serum, citrate-plasma, urine, cell lysate, culture medium
Research Areas
Obesity; Metabolic Disease
Datasheet